Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications

ESC Heart Fail. 2017 Nov;4(4):679-685. doi: 10.1002/ehf2.12210. Epub 2017 Sep 28.

Abstract

Aims: Acute heart failure (HF) is a frequent and life-threatening syndrome with heterogeneous clinical, haemodynamic, and neurohormonal features. This article describes the vascular phenotypes associated with acute decompensated chronic HF (ADCHF), and new-onset acute HF (NOAHF).

Data synthesis: Worsening of chronic HF occurs with full activation of adaptive mechanisms that maintain blood pressure (BP) and systemic perfusion. Rapid onset of HF in the setting of previous normal functioning heart not only does not allow full activation of adaptive mechanisms but also generates inappropriate responses from systemic endothelium leading to low BP/hypotension. Consequently, the treatment of ADCHF is based on diuretics and vasodilators, while in NOAHF, vasoconstrictors may be required to maintain BP to allow the correction of the acute cardiac disease.

Conclusions: Patients with ADCHF and NOAHF present different vascular phenotypes with treatment implications.

Keywords: Acute decompensated chronic heart failure; New-onset acute heart failure; Treatment; Vascular phenotypes.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Disease
  • Aged
  • Blood Vessels / physiopathology*
  • Cardiovascular Agents / therapeutic use*
  • Diagnostic Imaging / methods*
  • Disease Management*
  • Extracorporeal Membrane Oxygenation / methods*
  • Heart Failure* / diagnosis
  • Heart Failure* / physiopathology
  • Heart Failure* / therapy
  • Hemodynamics / physiology*
  • Humans
  • Male
  • Phenotype

Substances

  • Cardiovascular Agents